Author

Gregory R. J. Thatcher

University of ArizonaORCID 0000-0002-7757-1739Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Assay:imaging· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew L. PaekiD· 1 shared Annadurai AnandhaniD· 1 shared Briana A. Guzman· 1 shared Cameron Holberg· 1 shared Carly R. CabeliD· 1 shared Chonlarat WichaiditiD· 1 shared Christopher Penton· 1 shared Curtis A. ThorneiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Andrew L. PaekORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintSep 12, 2025

In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligands

Megan S. Laham, Martha S Ackerman-Berrier, Fahmida Alam…·Gregory R. J. Thatcher

The paper identifies diverse LXR ligand signatures using TR-FRET assays to guide the design of nonlipogenic ABCA1 inducers.

1 citation

humanproteomics

𝕏 PostBluesky

Pharmacology & ToxicologyFrontiers in Cell and Developmental BiologyPeer-reviewedMay 22, 2025

Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors.

Carly R. Cabel, Briana A. Guzman, Elaheh Alizadeh…·Curtis A. Thorne

This study uses high-throughput screens in human cells with authentic SARS-CoV-2 virus to identify neutralizing monoclonal antibodies and kinase inhibitors with minimal host toxicity.

1 citation

humanspatial transcriptomics

𝕏 PostBluesky